Literature DB >> 15189777

Angiotensin deficiency in mice leads to dilated cardiomyopathy.

Thomas Walther1, Paul Steendijk, Dirk Westermann, Claudia Hohmann, Karsten Schulze, Silvia Heringer-Walther, Heinz-Peter Schultheiss, Carsten Tschöpe.   

Abstract

To explore the role of angiotensin II, we assessed hemodynamics and cardiac function in angiotensinogen-deficient mice in comparison to wild-type animals. Left ventricular end-diastolic diameter and wall thickness were evaluated by echocardiography and systolic and diastolic left ventricular function by pressure-volume relations using a micro-conductance catheter. Compared to wild-type animals, the angiotensinogen-deficient mice were hypotensive and showed impaired systolic function. The hearts were dilated, demonstrated by echocardiography and by a right-ward shift of the pressure-volume loops, but end-diastolic pressure, isovolumic relaxation (tau) and diastolic stiffness were unchanged. Afterload, however, was reduced leading to maintained cardiac output. Although a blockade of the renin-angiotensin system via angiotensin converting enzyme inhibitors or angiotensin AT1 receptor antagonist is beneficial after cardiac failure, the absence of angiotensin peptides during the ontogenesis leads to dilated cardiomyopathy. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189777     DOI: 10.1016/j.ejphar.2004.04.032

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review.

Authors:  Congqing Wu; Hong Lu; Lisa A Cassis; Alan Daugherty
Journal:  N Am J Med Sci (Boston)       Date:  2011-10-01

2.  RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.

Authors:  Rukhsana Gul; Maya Ramdas; Chirag H Mandavia; James R Sowers; Lakshmi Pulakat
Journal:  Cardiorenal Med       Date:  2012-10-27       Impact factor: 2.041

3.  Cardiac overexpression of human VEGF(165) by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure.

Authors:  A E Loot; A J M Roks; D Westermann; H-D Orzechowski; C Tschöpe; J C Wilschut; R A Tio; W H van Gilst; R H Henning
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.